Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bojungikgitang is a traditional herbal medicine preparation widely used in Traditional Korean Medicine (TKM) and approved by the Korea Food and Drug Administration (KFDA) for the treatment of tinnitus in adults. It is a multi-component botanical formulation consisting of extracts from eight specific herbs: *Astragali radix*, white ginseng, *Atractylodes rhizome white*, *Glycyrrhizae resina*, *Angelicae gigantis radix*, *Fraxini cortex*, *Cimicifugae rhizoma*, and *Bupleuri radix*. While its exact mechanism of action is complex due to its multi-herb nature, it is thought to act through multiple biological pathways to alleviate symptoms of tinnitus. The Korea Health Industry Development Institute (KHIDI) has sponsored clinical research, including a Phase III trial evaluating its efficacy in adult patients with chronic tinnitus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bojungikgitang.